Scholars requires JavaScript. Please enable it in your browser to view this page.
Skip to main content
Scholars
Beta
Weill Cornell Medicine
Browse
About
Sign in
Loading co-authored publications…
Feedback
Scholars
/
Melissa Frey, MD
/
Co-authored with Luiza Perez
Co-authored publications
Melissa Frey, MD and Luiza Perez · 12 publications
CSV
Word
Understanding patient priorities: Sexual health and hereditary ovarian cancer syndromes.
Gynecologic oncology
· 2026
MF
Melissa Frey
LP
Luiza Perez
AK
Amita Kulkarni
XM
Xiaoyue Ma
SR
Shoshana Rosenberg
PMID:
41619425
·
DOI
·
Abstract
Decision-making surrounding ovarian cancer risk-reducing surgery: perspectives from a diverse population.
Menopause (New York, N.Y.)
· 2026
MF
Melissa Frey
LP
Luiza Perez
AK
Amita Kulkarni
LK
Laura Keenahan
+1 more →
SR
Shoshana Rosenberg
PMID:
41589845
·
DOI
·
Abstract
Cost-Effectiveness of BRCA1 Testing at Time of Obstetrical Prenatal Carrier Screening for Cancer Prevention
Obstetrical and Gynecological Survey
· 2025
Source: Scopus
·
DOI
Can we talk about sex? Feasibility of universal sexual health screening for BRCA1/2 patients.
The journal of sexual medicine
· 2025
MF
Melissa Frey
LP
Luiza Perez
AK
Amita Kulkarni
LM
Lauren Mitchell
CT
Charlene Thomas
+4 more →
PMID:
41025734
·
DOI
·
Abstract
Breast Cancer in the Ashkenazi Jewish Population
Current Breast Cancer Reports
· 2024
Source: Scopus
·
DOI
Considering screening for hereditary cancer syndromes at the time of obstetrical prenatal carrier screening.
Cancer
· 2024
MF
Melissa Frey
LP
Luiza Perez
MP
Michelle Primiano
SL
Steven Lipkin
RK
Rana Khan Fowlkes
+4 more →
PMID:
39037959
·
DOI
·
4 citations
Cost-effectiveness of BRCA1 testing at time of obstetrical prenatal carrier screening for cancer prevention.
American journal of obstetrics and gynecology
· 2024
MF
Melissa Frey
LP
Luiza Perez
MP
Malavika Prabhu
RS
Ravi Sharaf
PMID:
38621481
·
DOI
·
12 citations
·
Abstract
Cascade genetic testing for hereditary cancer syndromes: a review of barriers and breakthroughs.
Familial cancer
· 2024
MF
Melissa Frey
LP
Luiza Perez
XL
Xuan Li
PMID:
38530571
·
DOI
·
26 citations
·
Abstract
Integration and usability of a digital cancer risk stratification tool to optimize identification of patients at risk for hereditary cancers: A pilot study.
Gynecologic oncology
· 2024
MF
Melissa Frey
LP
Luiza Perez
EM
Emily M Webster
CT
Charlene Thomas
KB
Kemi Babagbemi
+1 more →
PMID:
38460222
·
DOI
·
6 citations
·
Abstract
Chatbot Artificial Intelligence for Genetic Cancer Risk Assessment and Counseling: A Systematic Review and Meta-Analysis.
JCO clinical cancer informatics
· 2023
MF
Melissa Frey
LP
Luiza Perez
EM
Emily M Webster
CT
Charlene Thomas
PJ
Paul J Christos
+6 more →
PMID:
37934933
·
PMCID:
PMC10730073
·
DOI
·
45 citations
·
Abstract
Partner and localizer of BRCA2 (PALB2) pathogenic variants and ovarian cancer: A systematic review and meta-analysis.
Gynecologic oncology
· 2023
MF
Melissa Frey
LP
Luiza Perez
PN
Priyanka Narayan
EM
Emily M Webster
BH
Benedict Harvey
+8 more →
PMID:
37651980
·
DOI
·
8 citations
·
Abstract
Patient perspectives on risk-reducing salpingectomy with delayed oophorectomy for ovarian cancer risk-reduction: A systematic review of the literature.
Gynecologic oncology
· 2023
MF
Melissa Frey
LP
Luiza Perez
EW
Emily Webster
LB
Leslie Bull
MD
Muhammad Danyal Ahsan
+4 more →
PMID:
37116391
·
PMCID:
PMC10650971
·
DOI
·
12 citations
·
Abstract